Rocio
Ferreiro Iglesias
Publicacións (46) Publicacións de Rocio Ferreiro Iglesias
2024
-
Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study
Journal of Clinical Medicine, Vol. 13, Núm. 2
2023
-
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)
Gastroenterologia y Hepatologia
-
Is Occupation a Risk Factor for Developing Inflammatory Bowel Disease? A Case–Control Study
Crohn's and Colitis 360, Vol. 5, Núm. 4
-
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU
American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046
-
Managing ulcerative colitis after surgery
Frontiers in Medicine
-
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort
Scandinavian Journal of Gastroenterology
2022
-
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)
Journal of Clinical Medicine
-
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU
Journal of Crohn's & colitis, Vol. 16, Núm. 7, pp. 1049-1058
-
Radon exposure and inflammatory bowel disease in a radon prone area
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 7, pp. 405-409
-
Recommendations of the Spanish Group on Crohn's Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel disease patients
Gastroenterologia y Hepatologia, Vol. 45, Núm. 10, pp. 805-818
-
SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project
Gastroenterologia y Hepatologia, Vol. 45, Núm. 10, pp. 737-741
-
The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study
Journal of Crohn's & colitis, Vol. 16, Núm. 11, pp. 1676-1686
-
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE study
Digestive and Liver Disease, Vol. 54, Núm. 1, pp. 76-83
-
Usefulness of peripheral blood monocyte count to predict relapse in patients with inflammatory bowel disease: a prospective longitudinal cohort study
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 1, pp. 10-15
-
Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practice
Digestive and Liver Disease, Vol. 54, Núm. 6, pp. 755-762
2021
-
Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study
Journal of Clinical Medicine, Vol. 10, Núm. 13
-
Liver X Receptor Exerts Anti-Inflammatory Effects in Colonic Epithelial Cells via ABCA1 and Its Expression Is Decreased in Human and Experimental Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Vol. 27, Núm. 10, pp. 1661-1673
-
Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study
Therapeutic Advances in Gastroenterology, Vol. 14
-
Role of quality of life as endpoint for inflammatory bowel disease treatment
International Journal of Environmental Research and Public Health, Vol. 18, Núm. 13
-
¿Qué debe conocer el cirujano del diagnóstico y tratamiento médico de la enfermedad de Crohn intestinal?
Practicum en coloproctología de la ACPE. Estrategias y técnicas para la práctica diaria (Ergon), pp. 343-353